Improved ATM Kinase Inhibitor KU-60019 Radiosensitizes Glioma Cells, Compromises Insulin, AKT and ERK Prosurvival Signaling, and Inhibits Migration and Invasion

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-0519
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Overexpression of RASD1 Inhibits Glioma Cell Migration/Invasion and Inactivates the AKT/mTOR Signaling Pathway

Scientific Reports
Multidisciplinary
2017English

Downregulated microRNA-30b-3p Inhibits Proliferation, Invasion and Migration of Glioma Cells via Inactivation of the AKT Signaling Pathway by Upregulating RECK

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

The ATM Inhibitor KU-55933 Suppresses Cell Proliferation and Induces Apoptosis by Blocking Akt in Cancer Cells With Overactivated Akt

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

All-Trans Retinoic Acid Inhibits Migration, Invasion and Proliferation, and Promotes Apoptosis in Glioma Cells In�vitro

Oncology Letters
Cancer ResearchOncology
2015English

ZNF259 Inhibits Non-Small Cell Lung Cancer Cells Proliferation and Invasion by FAK-AKT Signaling

Cancer Management and Research
Oncology
2017English

miR-142 Inhibits the Migration and Invasion of Glioma by Targeting Rac1

Oncology Reports
MedicineCancer ResearchOncology
2017English

Scutellaria?barbata D. Don Inhibits Migration and Invasion of Colorectal Cancer Cells via Suppression of PI3K/AKT and TGF‑β/Smad Signaling Pathways

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Evaluation of ATM Kinase Inhibitor KU-55933 as Potential Anti-Toxoplasma Gondii Agent

Frontiers in Cellular and Infection Microbiology
MedicineInfectious DiseasesImmunologyMicrobiology
2019English

Mn12Ac Inhibits the Migration, Invasion and Epithelial‑mesenchymal Transition of Lung Cancer Cells by Downregulating the WNT/Β‑catenin and PI3K/AKT Signaling Pathways

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy